Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles

Open access
Merle, Nicolas S., Grunenwald, Anne, Rajaratnam, Helena, Gnemmi, Viviane, Frimat, Marie, Figueres, Marie-Lucile, Knockaert, Samantha, Bouzekri, Sanah, Charue, Dominique, Noe, Remi, Robe-Rybkine, Tania, Le-Hoang, Marie, Brinkman, Nathan, Gentinetta, Thomas, Edler, Monika, Petrillo, Sara, Tolosano, Emanuela, Miescher, Sylvia, Le Jeune, Sylvain, Houillier, Pascal, Chauvet, Sophie, Rabant, Marion, Dimitrov, Jordan D., Fremeaux-Bacchi, Veronique, Blanc-Brude, Olivier P., Roumenina, Lubka T. · 2018 · JCI Insight

Abstract

In hemolytic diseases, such as sickle cell disease (SCD), intravascular hemolysis results in the release of hemoglobin, heme, and heme-loaded membrane microvesicles in the bloodstream. Intravascular hemolysis is thus associated with inflammation and organ injury. Complement system can be activated by heme in vitro. We investigated the mechanisms by which hemolysis and red blood cell (RBC) degradation products trigger complement activation in vivo. In kidney biopsies of SCD nephropathy patients and a mouse model with SCD, we detected tissue deposits of complement C3 and C5b-9. Moreover, drug-induced intravascular hemolysis or injection of heme or hemoglobin in mice triggered C3 deposition, primarily in kidneys. Renal injury markers (Kim-1, NGAL) were attenuated in C3-/- hemolytic mice. RBC degradation products, such as heme-loaded microvesicles and heme, induced alternative and terminal complement pathway activation in sera and on endothelial surfaces, in contrast to hemoglobin. Heme triggered rapid P selectin, C3aR, and C5aR expression and downregulated CD46 on endothelial cells. Importantly, complement deposition was attenuated in vivo and in vitro by heme scavenger hemopexin. In conclusion, we demonstrate that intravascular hemolysis triggers complement activation in vivo, encouraging further studies on its role in SCD nephropathy. Conversely, heme inhibition using hemopexin may provide a novel therapeutic opportunity to limit complement activation in hemolytic diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.96910

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 189

Metadata

Authors
Merle, N. S., Grunenwald, A., Rajaratnam, H., Gnemmi, V., Frimat, M., Figueres, M.-L., Knockaert, S., Bouzekri, S., Charue, D., Noe, R., Robe-Rybkine, T., Le-Hoang, M., Brinkman, N., Gentinetta, T., Edler, M., Petrillo, S., Tolosano, E., Miescher, S., Le Jeune, S., Houillier, P., Chauvet, S., Rabant, M., Dimitrov, J. D., Fremeaux-Bacchi, V., Blanc-Brude, O. P., & Roumenina, L. T.
Venue
JCI Insight
Published
2018-06-21
Volume
3
Issue
12
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2809354111
Cited by
189
References
9
FWCI
8.90
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. https://app.cochat.ai/papers/10.1172/jci.insight.96910
The paper
Merle, N. S., Grunenwald, A., Rajaratnam, H., Gnemmi, V., Frimat, M., Figueres, M.-L., Knockaert, S., Bouzekri, S., Charue, D., Noe, R., Robe-Rybkine, T., Le-Hoang, M., Brinkman, N., Gentinetta, T., Edler, M., Petrillo, S., Tolosano, E., Miescher, S., Le Jeune, S., . . . Roumenina, L. T. (2018). Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles. JCI Insight. https://doi.org/10.1172/jci.insight.96910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.